These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31500395)

  • 21. Proteasome-Independent Protein Knockdown by Small-Molecule Inhibitor for the Undruggable Lung Adenocarcinoma.
    Zhou W; Sun G; Zhang Z; Zhao L; Xu L; Yuan H; Li S; Dong Z; Song Y; Fang X
    J Am Chem Soc; 2019 Nov; 141(46):18492-18499. PubMed ID: 31657561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemically Induced Cellular Proteolysis: An Emerging Therapeutic Strategy for Undruggable Targets.
    Moon S; Lee BH
    Mol Cells; 2018 Nov; 41(11):933-942. PubMed ID: 30486612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A covalent BTK ternary complex compatible with targeted protein degradation.
    Schiemer J; Maxwell A; Horst R; Liu S; Uccello DP; Borzilleri K; Rajamohan N; Brown MF; Calabrese MF
    Nat Commun; 2023 Mar; 14(1):1189. PubMed ID: 36864023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small-Molecule PROTACS: New Approaches to Protein Degradation.
    Toure M; Crews CM
    Angew Chem Int Ed Engl; 2016 Feb; 55(6):1966-73. PubMed ID: 26756721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted Protein Degradation: from Chemical Biology to Drug Discovery.
    Cromm PM; Crews CM
    Cell Chem Biol; 2017 Sep; 24(9):1181-1190. PubMed ID: 28648379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors.
    Hua L; Zhang Q; Zhu X; Wang R; You Q; Wang L
    J Med Chem; 2022 Jun; 65(12):8091-8112. PubMed ID: 35686733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Light-Induced Protein Degradation with Photocaged PROTACs.
    Xue G; Wang K; Zhou D; Zhong H; Pan Z
    J Am Chem Soc; 2019 Nov; 141(46):18370-18374. PubMed ID: 31566962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted protein degradation by PROTACs.
    Neklesa TK; Winkler JD; Crews CM
    Pharmacol Ther; 2017 Jun; 174():138-144. PubMed ID: 28223226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photoactive Bifunctional Degraders: Precision Tools To Regulate Protein Stability.
    Kounde CS; Tate EW
    J Med Chem; 2020 Dec; 63(24):15483-15493. PubMed ID: 33226810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action.
    Riching KM; Mahan S; Corona CR; McDougall M; Vasta JD; Robers MB; Urh M; Daniels DL
    ACS Chem Biol; 2018 Sep; 13(9):2758-2770. PubMed ID: 30137962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of Hedgehog Antagonists for Cancer Therapy.
    Khatra H; Bose C; Sinha S
    Curr Med Chem; 2017; 24(19):2033-2058. PubMed ID: 28302010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monomeric Targeted Protein Degraders.
    Hanan EJ; Liang J; Wang X; Blake RA; Blaquiere N; Staben ST
    J Med Chem; 2020 Oct; 63(20):11330-11361. PubMed ID: 32352776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression.
    Zhou B; Hu J; Xu F; Chen Z; Bai L; Fernandez-Salas E; Lin M; Liu L; Yang CY; Zhao Y; McEachern D; Przybranowski S; Wen B; Sun D; Wang S
    J Med Chem; 2018 Jan; 61(2):462-481. PubMed ID: 28339196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterobifunctional Molecules Induce Dephosphorylation of Kinases-A Proof of Concept Study.
    Yamazoe S; Tom J; Fu Y; Wu W; Zeng L; Sun C; Liu Q; Lin J; Lin K; Fairbrother WJ; Staben ST
    J Med Chem; 2020 Mar; 63(6):2807-2813. PubMed ID: 31874036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical control of targeted protein degradation.
    Reynders M; Trauner D
    Cell Chem Biol; 2021 Jul; 28(7):969-986. PubMed ID: 34115971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the undruggable proteome: the small molecules of my dreams.
    Crews CM
    Chem Biol; 2010 Jun; 17(6):551-5. PubMed ID: 20609404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Nuclear Receptors with PROTAC degraders.
    Flanagan JJ; Neklesa TK
    Mol Cell Endocrinol; 2019 Aug; 493():110452. PubMed ID: 31125586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders.
    Hughes SJ; Ciulli A
    Essays Biochem; 2017 Nov; 61(5):505-516. PubMed ID: 29118097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligand-induced genetic degradation as a tool for target validation.
    Yesbolatova A; Tominari Y; Kanemaki MT
    Drug Discov Today Technol; 2019 Apr; 31():91-98. PubMed ID: 31200864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time to Get Turned on by Chemical Biology.
    Long MJC
    Chembiochem; 2021 Mar; 22(5):814-817. PubMed ID: 33174365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.